Dry Suspension Formulation of Taste Masked Antibiotic Drug for Pediatric Use

Dry suspension is commercial dry mixtures that require addition of water at the time of dispensing. The major consequence of the bitter taste is to restrict greatly the further development of oral preparations and clinical applications of these drugs. People wish to take effective drugs that have a nice taste can be administered easily. Accordingly, it is important to mask the unpalatable taste of a drug in order to improve the product quality. The solvent evaporation process is used for microencapsulation which is carried out in a liquid manufacturing vehicle. Eudragit L100 is used as taste masking agent . FT-IR study shows that there is no significant interactions occurring between drug and excipients. The suspension prepared was evaluated for various parameters like sedimentation volume, degree of flocculation, drug content and In-vitro dissolution time. All the parameters were found to be within limits. When the results were compared with marketed preparation suspension was found to be better with respect to marketed preparation.

[1]  Sanjay Bajaj,et al.  Stability Testing of Pharmaceutical Products , 2012, Journal of Applied Pharmaceutical Science.

[2]  Sushant Kumar MASKING OF BITTER TASTE OF CLARITHROMYCIN BY MICROENCAPSULATION USING HYDROPHILIC POLYMERS BLENDS AND THEIR EVALUATION , 2010 .

[3]  R. Mutahar,et al.  Formulation and stability study of palatable norfloxacin dry syrup: comparison among different preparation methods , 2010 .

[4]  M. Maghsoodi Physicomechanical Properties of Naproxen-Loaded Microparticles Prepared from Eudragit L100 , 2009, AAPS PharmSciTech.

[5]  Y. B. Chavan,et al.  Taste Masking Methods and Techniques in Oral Pharmaceuticals: Current Perspectives , 2009 .

[6]  Roderick B. Walker,et al.  The Evaluation of Eudragit Microcapsules Manufactured by Solvent Evaporation Using USP Apparatus 1 , 2009 .

[7]  H. Prado ACRYLIC POLYELECTROLYTES AS TASTE MASKING AGENTS IN ORAL SOLUTION DOSAGE FORMS , 2008 .

[8]  K. D. Tripathi,et al.  Essentials of Medical Pharmacology , 2004 .

[9]  Jain Formulation and Evaluation of Reconstitutable Oral Suspension of Ambroxol HCl and Azithromycin , 2003 .

[10]  R. Abuzarur-Aloul,et al.  Critical dissolution tests of oral systems based on statistically designed experiments. I. Screening of critical fluids and in vitro/in vivo modelling of extended release coated spheres , 1997 .

[11]  Joseph L. Kanig,et al.  The theory and practice of industrial pharmacy , 1970 .

[12]  S. H. Fox The Theory and Practice of Industrial Pharmacy , 1970 .

[13]  G. S. Banker,et al.  Micromeritics of granular pharmaceutical solids. II. Factors involved in the sieving of pharmaceutical granules. , 1966, Journal of pharmaceutical sciences.

[14]  G. S. Banker,et al.  Micromeritics of granular pharmaceutical solids. I. Physical properties of particles prepared by five different granulation methods. , 1966, Journal of pharmaceutical sciences.